BRK protein tyrosine kinase and encoding nucleic acid
US6051221A · kind A · utility
0Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1996 |
| Grant date | Apr 18, 2000 |
| Priority date | — |
| Expiry date | Jun 10, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a novel tyrosine kinase designated brk and the use of this tyrosine kinase in the development of diagnostic and therapeutic approaches to cancer. The novel tyrosine kinase was isolated from a human metastatic breast tumor using a PCR based differential screening approach and has the deduced amino acid sequence shown in SEQ ID NO:2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.